Least developed countries vs Zambia: Antiretroviral therapy coverage
Least developed countries
82.5%
in 2024
Zambia
94.0%
in 2024
Least developed countries rank
10th
Zambia rank
7th
Antiretroviral therapy coverage over time
- Least developed countries
- Zambia
How they compare
Zambia currently reports 94.0% against 82.5% in Least developed countries, a difference of 11.5%.
That makes Zambia's figure about 1.1 times Least developed countries's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Zambia ahead.
Least developed countries ranks 10th and Zambia ranks 7th of 23 groups.
Zambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Least developed countries | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.3% | 9.9% | 4.6% | Zambia |
| 2010s | 43.0% | 59.1% | 16.1% | Zambia |
| 2020s | 75.5% | 90.4% | 14.9% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Least developed countries or Zambia?
- Zambia, at 94.0% against 82.5% in Least developed countries as of 2024.
- What is the difference in antiretroviral therapy coverage between Least developed countries and Zambia?
- 11.5%, with Zambia ahead.
- How many years of comparable data are there for Least developed countries and Zambia?
- 25 years are reported by both, from 2000 to 2024.
- How do Least developed countries and Zambia rank globally for antiretroviral therapy coverage?
- Least developed countries ranks 10th and Zambia ranks 7th of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.